Clinical trials
Completed Arterial Occlusive Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
130 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 10 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 10 |
| 2019 | 10 |
| 2020 | 8 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 130 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 9 |
| C. R. Bard | 5 |
| Boston Scientific Corporation | 4 |
| Medtronic Vascular | 4 |
| Beijing Northland Biotech. Co., Ltd. | 3 |
| Cordis US Corp. | 3 |
| ARCA Biopharma, Inc. | 2 |
| AnGes USA, Inc. | 2 |
| Brigham and Women's Hospital | 2 |
| Duke University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arterial Occlusive Diseases | 130 |
| Cardiovascular Diseases | 40 |
| Coronary Artery Disease | 36 |
| Vascular Diseases | 31 |
| Arteriosclerosis | 28 |
| Coronary Disease | 28 |
| Peripheral Vascular Diseases | 28 |
| Myocardial Ischemia | 25 |
| Peripheral Arterial Disease | 22 |
| Heart Diseases | 21 |
Trials
Showing 26 to 50 of 130. Each trial links to its page on Pharma Observatory.
30 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.